Skip to main content
Premium Trial:

Request an Annual Quote

BGI Health, Turkish Partners Sign MOU to Conduct Genetic Testing

NEW YORK (GenomeWeb News) – BGI Health and partners in Turkey have inked a memorandum of understanding to bring genetic testing technologies, including non-invasive fetal trisomy testing, to that country, BGI Health announced this week.

The deal is between BGI Health — a commercial arm of BGI — and Turkish healthcare services provider Acibadem Healthcare Group Genetic Diagnostic Center in cooperation with Turkish firm Genoks Company Molecular Biology. According to BGI Health, the partnership will conduct genetic testing of monogenic disorders, exome sequencing-based personalized medicine, non-invasive fetal trisomy testing, and HLA genotyping, among other testing efforts.

Financial and other terms of the deal were not disclosed.

Ning Li, director of BGI-Europe, said in a statement that the collaboration will "advance the clinical applications of genetic testing technologies and develop better solutions to address the challenges of hereditary diseases."

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.